IMUNOMODULADORES - 1º SEMESTRE
Buyer: Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)
- Published
- 12 April 2024
- Estimated value
- €1,618,302
- Place of performance
- PT300
- Procedure
- Restricted procedure
- Notice number
- 00218050-2024
- Reference
- 645003b0-aee4-4a76-9379-653312884f1d
- Official source
- Official source
CPV codes
- 33690000Medicamentos diversos
Description
IMUNOMODULADORES - 1º SEMESTRE
Lots (13)
| Lot | Description | CPV code | Amount |
|---|---|---|---|
| 1 | BEVACIZUMAB 25 MG/ML SOL INJ FR 4 ML IV (AVASTIN) | 33600000 Productos farmacéuticos | €9,474 |
| 2 | OBINUTUZUMAB 25 MG/ML SOL INJ FR 40 ML IV | 33600000 Productos farmacéuticos | €56,224 |
| 3 | PERTUZUMAB 420 MG/14 ML SOL INJ FR 14 ML IV | 33600000 Productos farmacéuticos | €405,769 |
| 4 | RITUXIMAB 100 MG/10 ML SOL INJ FR 10 ML IV | 33600000 Productos farmacéuticos | €14,176 |
| 5 | RITUXIMAB 120 MG/ML SOL INJ FR 11.7 ML SC | 33600000 Productos farmacéuticos | €255,504 |
| 6 | RITUXIMAB 500 MG/50 ML SOL INJ FR 50 ML IV | 33600000 Productos farmacéuticos | €85,913 |
| 7 | TOCILIZUMAB 162 MG/0.9 ML SOL INJ CANETA 0.9 ML SC | 33600000 Productos farmacéuticos | €31,096 |
| 8 | TOCILIZUMAB 20 MG/ML SOL INJ FR 20 ML IV | 33600000 Productos farmacéuticos | €27,706 |
| 9 | TOCILIZUMAB 20 MG/ML SOL INJ FR 4 ML IV | 33600000 Productos farmacéuticos | €8,354 |
| 10 | TRASTUZUMAB 600 MG/5 ML SOL INJ FR 5 ML SC | 33600000 Productos farmacéuticos | €476,698 |
| 11 | TRASTUZUMAB EMTANSINA 100 MG PÓ CONC SOL INJ FR IV | 33600000 Productos farmacéuticos | €131,023 |
| 12 | TRASTUZUMAB EMTANSINA 160 MG PÓ CONC SOL INJ FR IV | 33600000 Productos farmacéuticos | €113,451 |
| 13 | MICOFENOLATO DE MOFETIL 1000 MG/5 ML PÓ SUSP ORAL FR 175 ML | 33600000 Productos farmacéuticos | €2,913 |
Award criteria
- Price — 100%
Awards
| Awarded to | Amount | Date |
|---|---|---|
| ROCHE FARMACEUTICA QUIMICA, LDA | — | — |
| ROCHE FARMACEUTICA QUIMICA, LDA | — | — |
| ROCHE FARMACEUTICA QUIMICA, LDA | — | — |
| ROCHE FARMACEUTICA QUIMICA, LDA | — | — |
| ROCHE FARMACEUTICA QUIMICA, LDA | — | — |
| ROCHE FARMACEUTICA QUIMICA, LDA | — | — |
| ROCHE FARMACEUTICA QUIMICA, LDA | — | — |
| ROCHE FARMACEUTICA QUIMICA, LDA | — | — |
| ROCHE FARMACEUTICA QUIMICA, LDA | — | — |
| ROCHE FARMACEUTICA QUIMICA, LDA | — | — |
Official publications
- TED · 00218050-2024 · 12 April 2024
- OJS · 73/2024 · 12 April 2024
Other tenders from Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)
- ANTIANDROGENIOS - APALUTAMIDA - 3 MESES
- ANTI-HEMORRÁGICOS
- IMUNOMODULADORES - RIBOCICLIB - 1º SEMESTRE
- IMUNOGLOBULINAS E SOROS - 1º SEMESTRE
- IMUNOMODULADORES - RIBOCICLIB - 1º SEMESTRE
- IMUNOMODULADORES - PEMBROLIZUMAB - 1 MÊS
- MEDICAMENTOS FIBROSE QUISTICA
- ANTIVIRICOS-BICTEGRAVIR+EMTRICITABINA+TENOFOVIR ALAFENAMIDA 2º SEMESTR
- ANTIANDROGENIOS - APALUTAMIDA - 2º SEMESTRE
- IMUNOMODULADORES - DARATUMUMAB - 2º SEMESTRE
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is €1,618,302.
- Who is the buyer of this tender?
- The contracting authority is Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) (European Union).
- How can I bid for public tenders in European Union?
- Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.